Accepted at 2:04 a.m. Nov, 01, 2023 by dollajas
Author: shmuelsash
Related Note: 1488765287344
Rationale for change

Keep wording consistent between cards

https://next.amboss.com/us/article/Tm06Ug?q=Warfarin-induced%20skin%20necrosis#Zcc47c1739f74989df3136377789a6028:~:text=Individuals%20with%20protein%20C%20deficiency%20are%20at%20a%20higher%20risk%20of%20developing%20warfarin%20necrosis.

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::03_Hypercoagulable_Disorders_DDx #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::07_Drug_reactions-hematologic #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#UWorld::Step::8872 #PANCE::EOR::Family_med #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::#UWSA3 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::05_Thrombophilias #AK_Step1_v12::#UWorld::Step::1088 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#UWorld::COMLEX::24199 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#AMBOSS::wx0hAR